Clinical Trial Update: Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating vinflunine as maintenance therapy in metastatic urothelial carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma Transitional Cell
• Urothelial Carcinoma

Drugs mentioned

• Vinflunine (vinflunine)

Snippet

Sponsor: Spanish Oncology Genito-Urinary Group | Conditions: Carcinoma, Transitional Cell | Phase 2 | Status: COMPLETED